Fulminant Legionellosis in Two Patients Treated with Infliximab for Crohn’s Disease: Case Series and Literature Review
Reads0
Chats0
TLDR
Two cases of fulminant pulmonary legionellosis are described, complicated by prolonged intensive care unit stays and acute respiratory distress syndrome, and who were recently treated with infliximab for Crohn's disease, and Physicians prescribing anti-TNF-alpha drugs should be aware of this association.Abstract:
Two cases of fulminant pulmonary legionellosis, complicated by prolonged intensive care unit stays and acute respiratory distress syndrome, and who were recently treated with infliximab for Crohn’s disease, are described. A review of the literature revealed three additional cases in patients with inflammatory bowel disease, and a total of 22 cases of Legionella pneumophila pneumonia in the context of treatment with antitumour necrosis (TNF)-alpha medications. The median age of the patients was 49 years, and men and women were affected equally. The case fatality rate was 14% (three of 22). Early recognition and treatment of this anti-TNF-alpha-related complication would likely result in reduced mortality and morbidity. Physicians prescribing anti-TNF-alpha drugs should be aware of this association.read more
Citations
More filters
Journal ArticleDOI
TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and future
TL;DR: The therapeutic modulation of TNF now moves into the era of personalized medicine with society's challenging expectations of durable treatment success and of achieving long-term disease remission.
Journal ArticleDOI
Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance
Kevin L. Winthrop,Shannon A. Novosad,John W. Baddley,L. Calabrese,Tom Chiller,Philip M. Polgreen,F Bartalesi,Marc Lipman,Xavier Mariette,Olivier Lortholary,Michael E. Weinblatt,Michael S. Saag,Josef S Smolen +12 more
TL;DR: The consensus group developed a working definition for OIs as ‘indicator’ infections, defined as specific pathogens or presentations of pathogens that ’indicate’ the likelihood of an alteration in host immunity in the setting of biologic therapy.
Journal ArticleDOI
Incidence and Risk Factors of Legionella pneumophila Pneumonia During Anti-Tumor Necrosis Factor Therapy: A Prospective French Study
Fanny Lanternier,Florence Tubach,Florence Tubach,Philppe Ravaud,Dominique Salmon,Pierre Dellamonica,Stéphane Bretagne,Marie Couret,Béatrice Bouvard,Michel Debandt,Isabelle Gueit,Jean-Pierre Gendre,Jean Leone,Nathalie Nicolas,Dider Che,Xavier Mariette,Xavier Mariette,Olivier Lortholary +17 more
TL;DR: The incidence and risk factors of legionellosis associated with tumor necrosis factor (TNF)-α antagonist use are described and the risk is higher for patients receiving anti-TNF-α monoclonal antibodies than soluble TNF-receptor therapy.
Journal ArticleDOI
Legionella pneumophila Type II Secretion Dampens the Cytokine Response of Infected Macrophages and Epithelia
Kessler McCoy-Simandle,Catherine R. Stewart,Jenny Dao,Sruti DebRoy,Ombeline Rossier,Paul J. Bryce,Nicholas P. Cianciotto +6 more
TL;DR: The impact of T2S on lung infection is a combination of at least three factors: the promotion of growth in macrophages, the facilitation ofrowth in epithelia, and the dampening of the chemokine and cytokine output from infected host cells.
Journal ArticleDOI
Crohn’s disease as an immunodeficiency
TL;DR: The pathogenesis of Crohn’s disease has been regarded as the consequence of a dysregulated T-cell-mediated response to intestinal microbes, but recent molecular biological and clinical investigations indicate that CD is actually a primary immunodeficiency.
References
More filters
Journal ArticleDOI
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.
TL;DR: In patients with active RA, anti-TNF therapy was not associated with increased risk of overall serious infection compared with DMARD treatment, after adjustment for baseline risk, but the rate of serious skin and soft tissue infections was increased, suggesting an important physiologic role of TNF in host defense in the skin andsoft tissues beyond that in other tissues.
Journal ArticleDOI
British Society for Rheumatology Biologics Register.
TL;DR: The British Society for Rheumatology established a register of patients newly treated with biological agents, the BSR Biologics Register (BSRBR), which became active in January 2002 and is recruiting a comparison cohort of patients with rheumatoid arthritis treated with standard disease modifying antirheumatic drugs.
Journal ArticleDOI
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up
Anna Kohn,Marco Daperno,Alessandro Armuzzi,Maria Cappello,Livia Biancone,Ambrogio Orlando,Angelo Viscido,Vito Annese,Gabriele Riegler,Gianmichele Meucci,M. Marrollo,R. Sostegni,Antonio Gasbarrini,S. Peralta,Cosimo Prantera +14 more
TL;DR: Severe ulcerative colitis is a life‐threatening disorder, despite i.v. glucocorticoids treatment, and infliximab has been proposed as a safe rescue therapy.
Journal ArticleDOI
Emergence of Legionella pneumophila Pneumonia in Patients Receiving Tumor Necrosis Factor–α Antagonists
Florence Tubach,Philippe Ravaud,Philippe Ravaud,Dominique Salmon-Ceron,N. Petitpain,O. Brocq,F. Grados,J. C. Guillaume,J. Leport,A. Roudaut,Elisabeth Solau-Gervais,Marc Lémann,Xavier Mariette,Olivier Lortholary,Olivier Lortholary +14 more
TL;DR: In patients receiving anti-TNF-alpha who develop pneumonia, legionellosis should be systematically investigated, and first-line antibiotic therapy should be efficient against L. pneumophila.
Journal ArticleDOI
Legionella pneumophila pathogenesis and immunity.
TL;DR: New findings are described that demonstrate that various cytokines that define Th1 vs Th2 helper cell activity also are important in regulating resistance versus susceptibility to this ubiquitous microorganism.